Form 4: Natera Legal Officer Sells Over $3.4 Million in Stock Under Pre-Arranged Trading Plan

Natera's SEC and Chief Legal Officer, Daniel Rabinowitz, executed multiple stock sales totaling over $3.4 million in June and July 2025, primarily under a Rule 10b5-1 trading plan.

Summary

• Daniel Rabinowitz, Natera's SEC and Chief Legal Officer, sold a total of 20,372 shares of Natera, Inc. common stock across several transactions in June and July 2025.
• On June 18, 2025, 10,000 shares were sold at a weighted average price of $170.1795 per share.
• On June 20, 2025, two separate sales occurred: 7,630 shares at a weighted average price of $170.6305 per share and 2,278 shares at a weighted average price of $171.4973 per share.
• These sales, totaling 19,908 shares, were conducted under a Rule 10b5-1 trading plan adopted on June 14, 2024, and amended on March 14, 2025.
• On July 20, 2025, 856 Restricted Stock Units (RSUs) vested, converting into 856 shares of common stock.
• On July 21, 2025, 464 shares were sold at $139.29 per share to cover tax withholding obligations related to the RSU vesting, also pursuant to a written instruction intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, Daniel Rabinowitz beneficially owns 204,158 shares of Natera common stock and 1,712 Restricted Stock Units.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider sales, even though they were pre-planned under a 10b5-1 plan. While the plan mitigates the negative implication of opportunistic selling, a large reduction in insider holdings can still be viewed with caution by investors. The RSU vesting is a positive for the individual, but the net effect of the transactions is a decrease in direct ownership.

Positives

• Vesting of 856 Restricted Stock Units (RSUs) on July 20, 2025, indicates continued compensation and retention of a key officer.
• The majority of the sales were conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to liquidity rather than a reaction to immediate negative news.

Negatives

• Significant insider sales totaling 20,372 shares, valued at approximately $3.46 million, could be perceived negatively by the market as a reduction in insider ownership.
• The sale price for tax withholding shares on July 21, 2025 ($139.29), was notably lower than the prices for the other sales in June 2025 (ranging from $170.00 to $171.74).

Risks

• Market perception of insider selling, even if pre-planned, can sometimes lead to negative sentiment or speculation about the company's future prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The filing does not contain direct quotes or paraphrased statements from company management, as it is a transactional report.

Industry Context

Insider transactions, such as those reported in this Form 4, are a routine part of executive compensation and personal financial planning across all industries. While the specific amounts and timing are unique to Natera, the mechanism of using a Rule 10b5-1 plan for pre-scheduled sales is a common practice for corporate insiders to manage liquidity and avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• This filing details individual insider stock transactions, which are not typically compared to industry-wide performance benchmarks or specific company projects.
• The use of a Rule 10b5-1 trading plan for these sales aligns with standard corporate governance practices for managing insider stock sales transparently and mitigating potential insider trading concerns, a practice common among publicly traded companies like Illumina, Exact Sciences, or Guardant Health in the diagnostics and genomics sector.

Stakeholder Impact

• Shareholders may interpret the significant insider sales as a signal, potentially leading to increased scrutiny of the company's near-term prospects, despite the sales being pre-planned.
• Employees, particularly those with equity compensation, might observe the executive's liquidity events as part of the normal course of equity vesting and monetization.

Next Steps

• Remaining Restricted Stock Units will continue to vest in 12 equal quarterly installments following January 20, 2023.

Key Dates

Recommendation

While the filing reports significant insider sales, these transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which suggests a systematic approach to liquidity rather than a reaction to adverse company-specific news. The vesting of RSUs also indicates ongoing executive compensation. Given the pre-planned nature, these sales do not necessarily signal a negative outlook for the company's fundamentals, but rather a personal financial decision. Investors should hold and monitor the company's operational performance and broader market trends rather than reacting solely to these expected insider transactions.

Keywords

Natera, NTRA, insider trading, Form 4, stock sale, Rule 10b5-1, Daniel Rabinowitz, Restricted Stock Units, RSU vesting, officer transaction, legal officer